Home

Rein Arktis Nuklear nmd pharme Sollst Nicht genug Kindergarten

NMD Pharma A/S | LinkedIn
NMD Pharma A/S | LinkedIn

NMD Pharma - Inkef capital
NMD Pharma - Inkef capital

NMD Pharma
NMD Pharma

Big deal: NMD flexes series A muscles - Global University Venturing
Big deal: NMD flexes series A muscles - Global University Venturing

Management — NMD Pharma
Management — NMD Pharma

NMD Pharma company information, funding & investors | Dealroom.co
NMD Pharma company information, funding & investors | Dealroom.co

Investors — NMD Pharma
Investors — NMD Pharma

NMD Pharma on Vimeo
NMD Pharma on Vimeo

NMD Pharma is Strengthening Muscles in Neuromuscular Disorders
NMD Pharma is Strengthening Muscles in Neuromuscular Disorders

NMD Pharma A/S | LinkedIn
NMD Pharma A/S | LinkedIn

NMD Pharma picked as Biotech of the Week by Labiotech.eu — NMD Pharma
NMD Pharma picked as Biotech of the Week by Labiotech.eu — NMD Pharma

Management — NMD Pharma
Management — NMD Pharma

Company Presentation
Company Presentation

NMD Pharma A/S | LinkedIn
NMD Pharma A/S | LinkedIn

Denmark in New York on Twitter: "#DKBIO17 is "a great opportunity for us to  broaden our scope and look for investors.” - Thomas H. Pedersen, CEO, NMD  Pharma… https://t.co/AUeO5JqgX6"
Denmark in New York on Twitter: "#DKBIO17 is "a great opportunity for us to broaden our scope and look for investors.” - Thomas H. Pedersen, CEO, NMD Pharma… https://t.co/AUeO5JqgX6"

Labiotech.eu on Twitter: "NMD Pharma, from @AarhusUni, is willing to tackle  Neuromuscular Transmission Disorders #BioEquity2016… "
Labiotech.eu on Twitter: "NMD Pharma, from @AarhusUni, is willing to tackle Neuromuscular Transmission Disorders #BioEquity2016… "

NMD Pharma Receives Approval to Start a combined Phase I/IIa Clinical Trial  of NMD670 for the Treatment of Symptoms of Myasthenia Gravis
NMD Pharma Receives Approval to Start a combined Phase I/IIa Clinical Trial of NMD670 for the Treatment of Symptoms of Myasthenia Gravis

NMD Pharma, finalist i Life Sciences kategorien - EY Danmark
NMD Pharma, finalist i Life Sciences kategorien - EY Danmark

Detailed Description | NMD-GPS
Detailed Description | NMD-GPS

Neuromuscular Drug Development Summit (NMD) - Pharma Journalist
Neuromuscular Drug Development Summit (NMD) - Pharma Journalist

Nete Huus's email & phone | NMD Pharma ApS's Senior Scientist email
Nete Huus's email & phone | NMD Pharma ApS's Senior Scientist email

NMD Pharma - Capnova
NMD Pharma - Capnova

NMD Pharma Initiates a Combined Phase I/IIa Clinical Trial of NMD670 for  the Treatment of Symptoms of Myasthenia Gravis
NMD Pharma Initiates a Combined Phase I/IIa Clinical Trial of NMD670 for the Treatment of Symptoms of Myasthenia Gravis